Eleventh Starr Cancer Consortium Grant Competition

  • Modulation of Viral Latency in EBV-associated Lymphomas as a Mechanism to Sensitize Tumors to EBV-directed Cellular Therapy

    Principal Investigator: 

    • Lisa Giulino Roth, MD, Weill Cornell Medicine

    Co-Principal Investigators: 

    • Benjamin Gewurz, MD, PhD, The Broad Institute of MIT and Harvard
    • Richard O'Reilly, MD, Memorial Sloan Kettering Cancer Center
    • Ethel Cesarman, MD, PhD, Weill Cornell Medicine
    Abstract 
  • Deciphering Signatures of Broken DNA Repair Pathways in Long-range Cancer Whole Genome Sequences

    Principal Investigator: 

    • Marcin Imielinski, MD, PhD, Weill Cornell Medicine

    Co-Principal Investigators: 

    • Simon Powell, MD, PhD, Memorial Sloan Kettering Cancer Center
    • Jorge Reis-Filho, MD, PhD, Memorial Sloan Kettering Cancer Center
    Abstract 
  • The mRNA Methylation Program in Leukemia

    Principal Investigator: 

    • Michael Kharas, PhD, Memorial Sloan Kettering Cancer Center

    Co-Principal Investigator: 

    • Samie Jaffrey, MD, PhD, Weill Cornell Medicine
    Abstract 
  • Defining Key Genomic Alterations in the Carcinogenesis of Colitis-associated Cancers

    Principal Investigator: 

    • Rona Yaeger, MD, Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators: 

    • David Kelsen, MD, Memorial Sloan Kettering Cancer Center
    • Adam Bass, MD, The Broad Institute of MIT and Harvard
    Abstract 
  • Defining the Cellular Origin and Mechanistic Basis for Therapy Resistant B-Cell Lymphomas

    Principal Investigator: 

    • Ari Melnick, MD, Weill Cornell Medicine

    Co-Principal Investigators: 

    • Gabriel Victora, PhD, The Rockefeller University
    • Olivier Elemento, PhD, Weill Cornell Medicine
    Abstract 
  • Dissecting the Metabolic Regulation of Tumor Initiating Stem Cells

    Principal Investigator: 

    • Elaine Fuchs, PhD, The Rockefeller University

    Co-Principal Investigator: 

    • Lydia Finley, PhD, Memorial Sloan Kettering Cancer Center
    Abstract 
  • Biochemical and Genetic Investigation of Oncogenic TOR-dependent Regulation of RNA Metabolism and Tumorigenesis using Cross-species Approaches

    Principal Investigator:

    • John Blenis, PhD, Weill Cornell Medicine

    Co - Principal Investigator:

    • Norbert Perrimon, PhD, The Broad Institute of MIT and Harvard
    Abstract 
  • Clonal Hematopoiesis as a Driver of Adverse Clinical Outcome

    Principal Investigator:

    • Ross Levine, MD, Memorial Sloan Kettering Cancer Center 

    Co-Principal Investigators:

    • Benjamin Ebert, MD, PhD, The Broad Institute of MIT and Harvard
    • Michael Berger, PhD, Memorial Sloan Kettering Cancer Center
    • Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center
    Abstract 
  • High Throughput Identification of Apoptosis Sensitizing Compounds in Fibrolamellar Hepatocellular Carcinoma

    Principal Investigator:

    • Sanford Simon, PhD, The Rockefeller University

    Co-Principal Investigators:

    • Anthony Letai, MD, PhD, The Broad Institute of MIT and Harvard
    • Michael LaQuaglia, MD, Memorial Sloan Kettering Cancer Center 
    Abstract